/주식/ADUS
ADUS

ADUS

USD

Addus HomeCare Corporation Common Stock

$100.580+1.490 (1.504%)

실시간 가격

Healthcare
Medical Care Facilities
미국

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$99.090

고가

$100.780

저가

$98.960

거래량

0.01M

기업 기본 정보

시가총액

1.9B

산업

Medical Care Facilities

국가

United States

거래 통계

평균 거래량

0.23M

거래소

NMS

통화

USD

52주 범위

저가 $88.96현재가 $100.580고가 $136.72

AI 분석 리포트

마지막 업데이트: 2025년 4월 24일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

ADUS: Addus HomeCare Corporation Common Stock - What's Happening and What to Watch

Stock Symbol: ADUS Generate Date: 2025-04-24 03:54:56

Alright, let's break down what's been going on with Addus HomeCare stock lately and what the tea leaves seem to be suggesting.

Recent News Buzz

The main chatter around ADUS right now seems pretty positive, at least from one corner of the market. We've seen JMP Securities, an investment firm, come out twice in April (once on the 10th and again on the 22nd) saying they still like the stock a lot. They're sticking with a "Market Outperform" rating, which is basically analyst-speak for "we think this stock will do better than the overall market." Plus, they're keeping a pretty ambitious price target of $150 on it. That's a good chunk higher than where the stock is trading right now.

On a different note, the company itself announced it's going to release its first-quarter earnings results on May 5th. This is a big deal because it's when we'll get the latest official look at how the business is actually performing – things like how much money they made and whether they're growing. Earnings reports can often cause the stock price to jump or drop depending on the results.

So, the news vibe is a mix of positive analyst endorsement and anticipation for the upcoming financial report.

Checking the Price Action

Looking back at the stock's journey over the past few months, it's been quite a ride. Back in late January, shares were trading up around the $125-$130 mark. But then, things took a significant dip through February and March, with the price falling all the way down into the high $80s. That was a pretty rough patch.

However, since hitting those lows in March, the stock has started to climb back up. April has seen a steady recovery, pushing the price back into the $95-$100 range. The last few trading days show the stock hovering right around $98-$99.

Comparing this to the AI's short-term predictions, the AI model seems to think this recent upward trend might continue for a couple more days, predicting small percentage gains for today and the next two days.

Putting It All Together: Outlook & Ideas

Based on what we're seeing – the positive analyst view, the stock's recent bounce off its lows, and the AI's short-term bullish forecast – the immediate picture seems to lean towards the positive side. It looks like the stock is trying to recover some of the ground it lost earlier in the year.

What might this suggest?

  • Near-term leaning: The current situation appears to favor potential buyers or those already holding the stock. The momentum seems to be upward right now.
  • Potential Entry Consideration: If someone were considering getting in, the current price area, maybe around $98 or $99, could be a point to watch. The recommendation data even highlighted entry points around $97.74 and $98.25 recently. This area seems interesting because it's where the stock has been trading after its recent climb.
  • Potential Exit/Stop-Loss Consideration: Managing risk is always key. A potential stop-loss level to consider might be below the recent lows seen in March, perhaps somewhere below $90, or specifically around the $88.15 level mentioned in the recommendation data. This is a point where, if the stock falls below it, the recent recovery trend would likely be broken, suggesting it might be time to cut losses. For taking profits, the AI suggests a potential target around $121.73, while the analyst has a much higher $150 target. These are levels far above the current price, suggesting there could be room to run if the positive trend continues, but they are not guaranteed. The recommendation data also listed a very near-term take-profit at $99.91, which is almost here already.

Remember, the upcoming earnings report on May 5th is a significant event that could change this outlook quickly, depending on the results.

A Little Company Context

Just to keep in mind, Addus HomeCare is in the business of providing care services right in people's homes – things like helping with daily tasks, hospice care, and home health services. They serve a mix of clients, including government programs and insurance companies. So, news about healthcare policies, reimbursement rates, or demand for home-based care can be particularly important for this company's performance. The analyst's positive view and the upcoming earnings report are essentially market opinions and a look at how this specific home care business is navigating its environment.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

관련 뉴스

Analyst Upgrades

JMP Securities Reiterates Market Outperform on Addus HomeCare, Maintains $150 Price Target

JMP Securities analyst Nicholas Jones reiterates Addus HomeCare with a Market Outperform and maintains $150 price target.

더 보기
JMP Securities Reiterates Market Outperform on Addus HomeCare, Maintains $150 Price Target
BusinessWire

Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market

더 보기
Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call
Analyst Upgrades

JMP Securities Maintains Market Outperform on Addus HomeCare, Maintains $150 Price Target

JMP Securities analyst Constantine Davides maintains Addus HomeCare with a Market Outperform and maintains $150 price target.

더 보기
JMP Securities Maintains Market Outperform on Addus HomeCare, Maintains $150 Price Target

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 4월 27일 오후 08:59

약세중립강세

64.5% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
보통
트레이딩 가이드

진입점

$100.23

익절

$106.96

손절

$90.48

핵심 요소

PDI 9.6이(가) ADX 13.4과 함께 MDI 7.3 위에 있어 강세 추세를 시사합니다.
현재 가격이 지지선($100.25)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(2,944)의 3.5배로 극도로 강력한 매수 압력을 나타냅니다.
MACD 0.0602이(가) 신호선 0.0818 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기